The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10881 malaria professionals are enjoying the free benefits of MalariaWorld today

rubella

NOT Open Access | Immunogenicity and safety of the RTS,S/AS01 malaria vaccine co-administered with measles, rubella and yellow fever vaccines in Ghanaian children: A phase IIIb, multi-center, non-inferiority, randomized, open, controlled trial

March 23, 2020 - 14:50 -- NOT Open Access
Author(s): 
Asante KP, Ansong D, Ofori-Anyinam O, et al.
Reference: 
Vaccine. 2020 Mar 16. pii: S0264-410X(20)30358-3

To optimize vaccine implementation visits for young children, it could be efficient to administer the first RTS,S/AS01 malaria vaccine dose during the Expanded Programme on Immunization (EPI) visit at 6 months of age together with Vitamin A supplementation and the third RTS,S/AS01 dose on the same day as yellow fever (YF), measles and rubella vaccines at 9 months of age. We evaluated the safety and immunogenicity of RTS,S/AS01 when co-administered with YF and combined measles-rubella (MR) vaccines.

Subscribe to RSS - rubella